2006
Dionne, R.A., Yagiela J., Cote, C., Donaldson, M., Edwards, M., Greenblatt, D., Haas, D., Malviya, S., Milgrom, P., Moore, P., Shampaine, G., Silverman, M., Williams, R., Wilson, S. (in press). Balancing efficacy and safety for the use of oral sedation in dental outpatients. JADA. (in press)

Gordon, S.M. & Dionne, R.A. (2006). The integration of clinical research into dental therapeutics: Making treatment decisions. Journal of the American Dental Association, 136, 1701-1708.

Kim, H., Mittal, P.D., Iadarola, M.J., Dionne, R.A. (2006). Genetic predictors for acute experimental cold and heat pain sensitivity in humans. Journal of Medical Genetics 43(8): e40.

Lee, Y., Kim, H., Wu, T., Wang, X., Dionne, R.A. (2006). Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther 79:407-418.

Wang, X. Wu, T., Lee, Y. & Dionne, R.A. (2006). Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: Implication for the adverse effects of cyclooxygenase-2 inhibitors.  Clinical Pharmacology and Therapeutics, 79(4), 303-315.

Fall-Dickson, J.M. & Berger, A. (2006). Oral Manifestations and Complications of Cancer Treatment. In Berger etc. (Eds). Principles and Practice of Palliative Care and Supportive Oncology (3rd Edition). Philadelphia: Lippincott Williams & Wilkins.

Schubert, M., Fall-Dickson, J.M., Guadagnini, J.P., Boyd, K., Erickson, M. (2006). Oral manifestations. In Measuring therapeutic response in chronic GVHD trials: An instructional manual [CD]. Mitchell, S.A. and Pavletic, S.Z., eds. Silver Spring, MD: Palladian Partners.

Pavletic, Z.P., Martin, P., Lee, S.J., Mitchell, S., Jacobsohn, D., Cowan, E.W., Turner, M.L., Akpek, G., Gilman, A., McDonald, G., Schubert, M., Berger, A., Bross., P., Chien, J.W., Couriel, D., Dunn, J.P., Fall-Dickson, J.M. et al.(2006). Measuring Therapeutic Response in cGVHD, NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: IV: Response Criteria Working Group Report. Biology of Blood and Marrow Transplantation, 12, 252-266.

Goellner, S., Steinbach, D., Schenk, T., Gruhn, B., Zintl, F., Ramsay, E., Saluz, H.P. (2006) Childhood acute myelogenous leukaemia: Association between PRAME, apoptosis- and MDR-related gene expression. Eur J Cancer, 42(16):2807-14.

Wang, X.M., Wu, T.X., Hamza, M., Ramsay, E.S., Wahl, S.M., Dionne, R.A. (In press) Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain.

Lee, Y., Kim, H., Brahim, J., Rowan, J., Lee, G., Dionne, R.A. (In press). Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain.

Kim, H., Lee, H., Rowan, J., Brahim, J., Dionne, R.A. (2006).Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Molecular Pain 2(1):24.

Bevans, M. & Marden, S. (2006). Health-Related Quality of Life and Symptom Distress in Hispanic Patients Preparing for Hematopoietic Stem Cell Transplantation. The Journal of Multicultural Nursing and Health, 12: 2, 33-43.

Powers, A., Marden, S., McConnel, R., Leidy, K., Campbell, C., Soeken, K., Barker, C., Davey, R., Dybul, M. (2006). Effect of long-cycle structured intermittent versus continuous HAART on quality of life in patients with chronic HIV infection. AIDS, 20, 837-845.

Miller-Davis, C., Marden, S., Leidy, N.K. (2006). The New York Heart Association Classes and functional status: what are we really measuring? Heart Lung, 35(4):217-24.

Bevans, M.F., Marden, S., Leidy, N.K., Soeken, K., Cusack, G., Rivera, P., Mayberry, H., Bishop, M.R., Childs, R., Barrett, A.J.  (2006). Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant, 38(2):101-9.

Fogarty, P.F., Seggewiss, R., McCloskey, D.J., Boss, C.A., Dunbar, C.E., & Rick, M.E. (2006). Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura. Haematologica, 91(2):277-278.

Horne, M.K. & McCloskey, D.J. (2006). Factor V Leiden as a common genetic risk factor for venous thromboembolism. Journal of Nursing Scholarship, 38(1), 19-25.

Graves, E., Ramsay, E. & McCarthy, D.O. (2006).Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma. Research in Nursing Health. 29(2):87-97.

Woltz, P. Good Clinical Practices. Oncology Nurs Soc. (in press)

Woltz, P., Castro, K. & Parks, B. Care of Patients Undergoing Extracorporeal Photopheresis (ECP) to Treat Chronic Graft Versus Host Disease: Review of the Evidence. J Clinc Oncology. (in press)

2005
Dworkin, R.H., Turk, D.C., Farrar, J.T., Haythornwaite, J., Jensen, M.P., Katz, N.P., Kerns, R.D., Stucki, G., Allen, R.R., Bellamy, N., Carr, D.B., Chandler, J., Cowan, P. & Dionne, R.A. et al. (2005). Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain, 113, 9-19.

Warburton, G., Nares, S., Angelov, N., Brahim, J., Wahl, S.M. & Dionne, R.A. (2005). Transcriptional events in a clinical model of oral mucosal tissue injury and repair. Wound Repair and Regeneratin. 13, 19-26.

Dionne, R.A., Bartoshuk, L., Mogil, J. & Witter, J. (2005).Individual responder analyses for pain. Does one pain scale fit all? Trends in Pharmacology Science, 26, 125-120.

Lee, Y.S. & Dionne, R.A. (2005). Role of COX in acute pain and the use of non-selective and selective COX-2 inhibitors for the relief of acute pain. Current Pharmaceutical Design, 11, 1737-55.

Dionne, R.A., Kim, H-S., & Gordon, S.M. (2005). Acute and chronic dental and orofacial pain. In, McMahan S, Koltzenburg M (eds), Wall and Melzacks Textbook of Pain, Elsevier, 819-835.

Dionne, R.A. (2006). Evidence-based pharmacologic treatments for temporomandibular disorders. in, Laskin DM, Greene CS (eds): Temporomandibular disorders: An evidence based approach to diagnosis and treatment. Quintessence Books, 347-357.

Kim, H. & Dionne, R.A. (2005).Genetic influences on pain sensitivity and analgesic response. Pain Clinical Updates, 13, 1-4.

Marden, S. (2005). Technology dependence and health-related quality of life: a model. Journal of Advanced Nursing, 50(2), 187-95.

Mock, B.A., Zhang, S., Ramsay, E.S., Bliskovsky, V., Zhang, K., Shi, W. & DuBois, W. (2005). Strategies for dissecting complex traits associated with cancer: lessons from plasma cell tumors. AACR Education Book 2005. Philadelphia:AACR. p. 273-276.

2004
Kim, H., Neubert, J.K., San Miguel, A., Krishnaraju, K., Iadarola, M.J., Goldman. D., & Dionne, R.A. (2004). Genetic influence on variability in human pain sensitivity associated with gender, ethnicity and psychological temperament. Pain, 109, 488-496.

Dionne, R.A., Haynes, D., Brahim, J.S., Rowan, J.S., & Guivarch, P. (2004). Analgesic affects of microencapsulated flurbiprofen in the oral surgery model of acute pain. Journal of Clinical Pharmacology, 44, 1418-1424.

Ta, L.E. & Dionne, R.A. (2004). Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain, 111, 13-21.

Kim, H. & Dionne, R.A. (2004). Introduction to antinociceptive drugs. In, Yagiela J, Dowd FJ, Neidle EA, Pharmacology and Therapeutics for Dentistry, 5th Ed, Elsevier, Philadelphia.

Witter, J. & Dionne, R.A. (2004). What can chronic arthritis pain teach about developing new analgesic drugs? Arthritis Research & Therapy, 6, 279-281.

Gordon, S.M. & Dionne, R.A. (2004). The integration of clinical research into dental therapeutics: The role of astute clinician. Journal of the American Dental Association; 135, 1537-1542.

Kim, H., Neubert, J.K., Rowan, J., Brahim, J., Iadarola, M.J., & Dionne, R.A. (2004). Comparison of experimental and acute clinical pain responses in humans as pain phenotypes. Journal of Pain, 5, 377-384.

Phero, J.C., Becker, D.E. & Dionne, R.A. (2004). Contemporary trends in acute pain management. Current Opinions in Otolaryngology, 12, 209-216.

Gaston-Johansson, F., Lachica, E.M., Fall-Dickson, J.M., & Kennedy, M.J. (2004). Psychological Distress, Fatigue, Burden of Care, and Quality of Life in Primary Caregivers of Patients Undergoing Autologous Bone Marrow Transplantation. Oncology Nursing Forum, 31(6), 1161-1169.

Berger, A. & Fall-Dickson, J.M. (2004). Oral Complications. In V. T. DeVita, S. Hellman, S. A. Rosenberg (Eds.) Cancer: Principles and Practice of Oncology (7th ed.). Philadelphia:Lippincott Williams & Wilkins, 2523.

Fall-Dickson, J.M. (2004). Peer Viewpoint for a Biological Approach to Mucositis. (Sonis, ST). The Journal of Supportive Oncology, 2(1), 35-36. 

2003
Khan, A.A. & Dionne, R.A. (2003). COX-2 inhibitors for endodontic pain.  Endodontic Topics 3, 71-80.

Jaber, L., Swaim, W.D., & Dionne, R.A. (2003). Immunohistochemical localization of -opioid receptors in human dental pulp.  Journal of Endodontics, 29, 108-110.

Dionne, R.A. (2003). Relative efficacy of selective COX-2 inhibitors compared with over-the-counter ibuprofen. International Journal of Clinical Practice, Suppl. 135, 18-22.

Dionne, R.A., & Witter, J. (2003). NIH-FDA Analgesic Drug Development Workshop.  Translating Scientific Advances Into Improved Pain Relief.  Clinical Journal of Pain, 19, 139-147.

Dionne, R.A. (2003). Tramadol/Paracetamol, a Viewpoint. Drugs, 63, 1087-88.

Gordon, S.M., Heft, M.W., & Dionne, R.A., Jeffcoat, M.K., Alfano, M.C., Valakovic, R.W., Lipton, J.A.  (2003). Capacity for training in clinical research:  status and opportunities. Journal of Dental Education, 67, 623-630.

Dionne, R.A. & Witter, J. (2003). Improving analgesic drug development: What's needed? APS Bulletin, 13, 4-5.

Dionne, R.A., Gordon, S.M., Brahim, J.S., Rowan, J., Kent, A.A. (2003). Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation.  Journal of Oral and Maxillofacial Surgery; 61, 997-1003.

Wahl, S.M., McCartney-Francis, N., Chan, J., Dionne, R.A., Ta, L., & Orenstein, J.M. (2003). NO in experimental joint inflammation: benefit or detriment. Cells, Tissues, Organs, 174, 26-33

Turk, D.C., Dworkin, R.H., Allen, R.R., Bellamy, N., Brandenburg, N., Carr, D.B., Cleeland, C., Dionne, R.A., et al. (2003). Outcome domains in chronic pain clinical trial: IMMPACT consensus recommendation. Pain, 106, 337-345.

Witter, J., Simon, L., & Dionne, R.A. (2003) Are means meaningless? The application of individual responder analysis to analgesic drug development. APS Bulletin, 13, 1-8.

Kim, H., Neubert, J.K., Iadarola, M.J., Miguel, A.S., Goldman, D., & Dionne, R.A. (2003).Genetic influence on pain sensitivity in humans: Evidence of heritability related to single nucleotide polymorphisms in opioid receptor genes. In Proceedings of the World Congress on Pain.  IASP Press: Seattle, 513-520.

Bliskovsky, V., Ramsay, E.S., Scott, J., DuBois, W., Shi, W., Zhang, S., Qian, X., Lowy, D.R. & Mock, B.A. (2003). Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. Proceedings of the National Academy of Sciences,100: 14982-14987.

Zhang, S., Qian, X., Redman, C., Bliskovski, V., Ramsay, E.S., Lowy, D.R. & Mock, B.A. (2003). p16(INK4a) gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene, 22, 2285-2295.

2002 
Khan, A.A., Brahim, J.S., Rowan, J.S., & Dionne, R.A. (2002). In vivo selectivity of a selective COX-2 inhibitor in the oral surgery model. Clinical Pharmacological Therapy 72, 44-49.

Gordon, S.M., Brahim, J.S., Rowan, J., Kent, A.A., & Dionne, R.A. (2002).  Peripheral prostanoid levels and NSAID analgesia: replicate clinical trials in a tissue injury model.  Clinical Pharmacological Therapy 72, 175-83.

Gordon, S.M., Brahim, J., Dubner, R., McCullagh, L., Sang, C., & Dionne, R.A. (2002). Attentuation of pain in a randomized trial by suppression of peripheral nociceptive activity in the immediate postoperative period.  Anesthesia and Analgesia 95, 1351-57.

Ta, L.E., Phero, J.C., Pillemer, S.R., Hale-Donze, H., McCartney-Francis, N., Kingman, A., Max, M.B., Gordon, S.M., Wahl, S.M., & Dionne, R.A. (2002). Clinical evaluation of patients with TMJ implants. Journal of Oral Maxillofacial Surgery 60, 1289-99.

Fall-Dickson, J.M. (2002). Treatment of Stomatitis and Associated Oropharyngeal Pain in the Oncology Patient. In R. Dionne, J. Phero, & D. Becker (Eds.). Management of Pain and Anxiety in the Dental Office, 385-400, Philadelphia: Harcourt.